{"id":"NCT03693989","sponsor":"Laboratorios Sophia S.A de C.V.","briefTitle":"Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After Phacoemulsification","officialTitle":"Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for the Management of Inflammation and Pain After Phacoemulsification Compared to Prednisolone Acetate 1%.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-10-04","primaryCompletion":"2019-08-07","completion":"2019-10-22","firstPosted":"2018-10-03","resultsPosted":"2019-12-02","lastUpdate":"2019-12-02"},"enrollment":178,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Cataract"],"interventions":[{"type":"DRUG","name":"Difluprednate 0.05%","otherNames":["PRO-145"]},{"type":"DRUG","name":"Prednefrin","otherNames":["Difluprednate"]}],"arms":[{"label":"PRO-145.","type":"EXPERIMENTAL"},{"label":"Prednefrin","type":"ACTIVE_COMPARATOR"}],"summary":"objective: To evaluate the efficacy of the ophthalmic emulsion PRO-145 in the treatment of inflammation and pain after phacoemulsification.\n\nHypothesis:\n\nThe use of the ophthalmic emulsion PRO-145 is effective in decreasing the inflammatory response evaluated by means of cellularity in the anterior chamber, after phacoemulsification.\n\nMethodology:\n\nPhase III clinical trial, double-blind, controlled, parallel group, multicentre, randomized.\n\nNumber of patients:\n\n178 subjects divided into 2 groups (89 subjects per group), who will provide an eye for the evaluation of efficacy.\n\nDiagnosis and main inclusion criteria:\n\nDiagnosis: Postoperative phacoemulsification and foldable intraocular lens placement in a bag.","primaryOutcome":{"measure":"Visual Ability (VA)","timeFrame":"day 28 at the final visit","effectByArm":[{"arm":"PRO-145.","deltaMin":0.91,"sd":0.1},{"arm":"Prednefrin","deltaMin":0.87,"sd":0.2}],"pValues":[{"comp":"OG000 vs OG001","p":"0.065"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":31},"locations":{"siteCount":5,"countries":["Mexico"]},"refs":{"pmids":["32606573"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":85},"commonTop":["ocular burning","eye foreign body sensation","Blurred Vision","eye itching","red eye"]}}